Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionPathstone Holdings, LLC
Latest Disclosed Ownership325,687 shares
Latest Disclosed Value $ 11,991,467
Pathstone Holdings, LLC reports 5.61% decrease in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 11, 2026 - Pathstone Holdings, LLC filed a 13F-HR form disclosing ownership of 325,687 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $10,275,425 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 345,053 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -5.61% during the quarter. The current value of the position is $11,666,108 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 325,687 -19,366 -5.61 11,991 -31.70 0.0258
2026-02-13 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 345,053 43,507 14.43 17,556 4.92 0.0677
2025-11-13 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 301,546 21,387 7.63 16,733 -13.47 0.0639
2025-08-12 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 280,159 -59,969 -17.63 19,337 -18.47 0.0765
2025-05-15 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 340,128 65,227 23.73 23,717 0.29 0.1028
2025-02-14 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 274,901 -15,328 -5.28 23,649 -31.57 0.1045
2024-11-07 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 290,229 734 0.25 34,558 -16.37 0.1529
2024-08-14 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 289,495 12,207 4.40 41,323 16.00 0.1865
2024-05-13 2024-03-31 13F NOVO-NORDISK A S ADR 670100205 277,288 122,229 78.83 35,622 121.69 0.1660
2024-02-14 2023-12-31 13F NOVO-NORDISK A S ADR 670100205 155,059 155,059 16,069 0.0862
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.